Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.
复制标题
DOI:
10.1021/acs.jmedchem.7b00306
复制
发表时间:
2017-05-11
影响因子:
7.3
通讯作者:
Haendler B
中科院分区:
文献类型:
--
作者:
Bouché L;Christ CD;Siegel S;Fernández-Montalván AE;Holton SJ;Fedorov O;Ter Laak A;Sugawara T;Stöckigt D;Tallant C;Bennett J;Monteiro O;Díaz-Sáez L;Siejka P;Meier J;Pütter V;Weiske J;Müller S;Huber KVM;Hartung IV;Haendler B
Bromodomains (BD) are readers of lysine acetylation marks present in numerous proteins associated with chromatin. Here we describe a dual inhibitor of the bromodomain and PHD finger (BRPF) family member BRPF2 and the TATA box binding protein-associated factors TAF1 and TAF1L. These proteins are found in large chromatin complexes and play important roles in transcription regulation. The substituted benzoisoquinolinedione series was identified by high-throughput screening, and subsequent structure–activity relationship optimization allowed generation of low nanomolar BRPF2 BD inhibitors with strong selectivity against BRPF1 and BRPF3 BDs. In addition, a strong inhibition of TAF1/TAF1L BD2 was measured for most derivatives. The best compound of the series was BAY-299, which is a very potent, dual inhibitor with an IC50 of 67 nM for BRPF2 BD, 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2. Importantly, no activity was measured for BRD4 BDs. Furthermore, cellular activity was evidenced using a BRPF2– or TAF1–histone H3.3 or H4 interaction assay.